Results 101 to 110 of about 17,683 (178)

Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden. [PDF]

Ophthalmol Ther
Spartalis C, Ullrich M, Winkler S, Leisser C, Ruiss M, Pilwachs C, Findl O.   +6 more
europepmc   +1 more source

Association between optical coherence tomography biomarkers and systemic inflammatory indices in neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Kocamış Ö.
europepmc   +1 more source

MMP9 Genotype and Systemic T-Cell Subsets Correlate With Structural and Functional Outcomes in Neovascular Age-Related Macular Degeneration. [PDF]

Invest Ophthalmol Vis Sci
Martinez TL, Zacharias ZR, Lee K, Han IC, Jiao C, Bach BB, Roos B, Chava S, McCormick MM, Sinkey C, Wu AP, Mukhopadhyay C, Coussa RG, Russell J, Binkley EM, Boldt HC, Folk JC, Russell SR, Mullins RF, Fingert JH, Wang K, Abramoff MD, Stone EM, Scheetz TE, Houtman JCD, Sonka M, Sohn EH.   +26 more
europepmc   +1 more source

Rapid Fluid Resolution and Durability With Faricimab in Neovascular Age-Related Macular Degeneration.

JAMA Ophthalmol
Pitcher JD, Koh AHC, Tan CS, Vakharia P, Dagincourt N, Patel S, Yang M, Margaron P, Gallego-Pinazo R.   +8 more
europepmc   +1 more source

Choroidal changes correlate with type 1 neovascular activity in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. [PDF]

Br J Ophthalmol
Huang X, Chen J, Li J, Zhang G, Zhu X, Zhou M, Bo Q, Sun X.   +7 more
europepmc   +1 more source

Real-World Functional and Anatomical Outcomes of Intravitreal Faricimab in Suboptimal Responders With Neovascular Age-Related Macular Degeneration: A 24-Month Clinical Audit. [PDF]

Cureus
Sukumaran D, Benjamin D, Abdul Karim MN, Amankwah R, Maharajan P, Mubashar M, Sarmad A, Sharma P, Dhar-Munshi S.   +8 more
europepmc   +1 more source

Short-term efficacy of aflibercept 8 mg in refractory neovascular age-related macular degeneration: a retrospective case series from Taiwan. [PDF]

BMC Ophthalmol
Chi SC, Hwang DK, Chen SJ, Weng CC, Huang YM, Chou YB, Lin TC.   +6 more
europepmc   +1 more source

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. [PDF]

PLoS One
Iby J, Coulibaly L, Hollaus M, Yeghiazaryan L, Schmidt-Erfurth U, Bühl W, Sacu S.   +6 more
europepmc   +1 more source

Visual and Anatomic Outcomes of Faricimab in Naïve Neovascular Age-Related Macular Degeneration with Subretinal Hemorrhage: A Multi-Centre Retrospective Analysis. [PDF]

Clin Ophthalmol
Sivachandran N, Ji PX, Khan H, Pickel L, Mojumder O, Aziz AA, Khan H, Sulahria H, Gahn GM, Khanani AM.   +9 more
europepmc   +1 more source

PANoptosis-Related Diagnostic Biomarkers in Non-Neovascular Age-Related Macular Degeneration: An Integrative Transcriptomic and Experimental Study. [PDF]

Genet Res (Camb)
Li J, Ma Y, Hu M, Zhang Q, Wang A, Tang Q, Guo Q, Huang B.   +7 more
europepmc   +1 more source